Company Search:
Advanced Search
Sponsored Links
Nephros, Inc. Company Snapshot
Nephros, Inc. operates in the Surgical and medical instruments sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nephros with three other companies in this sector in the United States: Plus Therapeutics Inc (2018 sales of $6.65 million of which 33% was Consumable), Second Sight Medical Products Inc ($6.90 million ), and Isoray, Inc. ($5.92 million of which 100% was Medical Devices).

Sales Analysis. Nephros reported sales of $5.69 million for the year ending December of 2018. This represents an increase of 49.3% versus 2017, when the company's sales were $3.81 million. Sales at Nephros have increased during each of the previous five years (and since 2013, sales have increased a total of 227%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Nephros, Inc.
  Stock Performance Chart for Nephros, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): 8.35
(Figures in U.S. Dollars)
1 Week -7.2%   13 Weeks -22.5%  
4 Weeks 19.3%   52 Weeks 65.7%  
Nephros, Inc. Key Data:
  Ticker: NEPH Country: United States
  Exchanges: OTC Major Industry: Health Care Equipment & Services
    Sub Industry: Surgical & Medical Instruments
  2018 Sales 5,687,000
(Year Ending Jan 2019).
Employees: 8
  Currency: U.S. Dollars Market Cap: 65,000,867
  Fiscal Yr Ends: December Shares Outstanding: 7,784,535
  Share Type: Common Closely Held Shares: 1,065,948
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.